Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea

Published:2009-01 Issue:1 Volume:83 Page:106-116
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Mohan Viswanathan,Yang Wenying,Son Ho-Young,Xu Lei,Noble Liliane,Langdon Ronald B.,Amatruda John M.,Stein Peter P.,Kaufman Keith D.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference42 articles.

1. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans;Holst;Am. J. Physiol. Endocrinol. Metab.,2004

2. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007

3. The entero-insular axis in type 2 diabetes –incretins as therapeutic agents;Creutzfeldt;Exp. Clin. Endocrinol. Diabetes,2001

4. Biological actions and therapeutic potential of the glucagon-like peptides;Drucker;Gastroenterology,2002

5. Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?;Deacon;Expert. Opin. Investig. Drugs.,2004

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Efficacy and Safety of Tirzepatide in Asians and Non-Asians with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis;Diabetes Therapy;2024-02-24

2. Plasma proteome profiling reveals the therapeutic effects of the PPAR pan-agonist chiglitazar on insulin sensitivity, lipid metabolism, and inflammation in type 2 diabetes;Scientific Reports;2024-01-05

3. THE IMPACT OF SITAGLIPTIN IN PALMITIC ACID-INDUCED INSULIN RESISTANCE IN HUMAN HEPG2 CELLS THROUGH THE SUPPRESSOR OF CYTOKINE SIGNALING 3/PHOSPHOINOSITIDE 3-KINASE/PROTEIN KINASE B PATHWAY;J PHYSIOL PHARMACOL;2023

4. Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes;Journal of Endocrinological Investigation;2023-01-09

5. Glucagon-related advancements in diabetes therapy;Journal of Diabetology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3